Related Experiment Video
Updated: Aug 7, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Landscape of bronchopulmonary dysplasia: from mechanisms to management
Ya Pan1, Xueli Cheng1, Feng Tang2
1Department of Neonatology, Shenzhen Longhua Maternity and Child HealthCare Hospital, Shenzhen, Guangdong Province, China.
Insights
Bronchopulmonary dysplasia (BPD) in premature infants stems from complex prenatal and postnatal factors. Current treatments focus on supportive care, with a need for targeted therapies to improve long-term outcomes.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Developmental Biology
Background:
- Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease in premature infants.
- BPD leads to significant respiratory and neurodevelopmental issues, impacting long-term health.
- Despite advances in neonatal care, BPD remains a major cause of morbidity in extremely preterm infants.
Purpose of the Study:
- To review current evidence on the pathophysiology, risk factors, and therapeutic strategies for BPD.
- To synthesize findings from recent literature on BPD management.
- To identify gaps in knowledge and future research directions for BPD.
Main Methods:
- Comprehensive literature search of PubMed, Web of Science, and Embase.
- Inclusion of English-language studies published up to 2025, including original studies, reviews, and meta-analyses.
- Narrative synthesis of relevant findings on BPD pathophysiology, risk factors, and treatment.
Main Results:
- BPD is a multifactorial disorder involving impaired alveolarization and pulmonary vascular development due to prenatal and postnatal injuries.
- Key pathogenic pathways include oxidative stress, inflammation, dysregulated angiogenesis, and abnormal tissue repair.
- Preventive and therapeutic strategies include lung-protective ventilation, surfactant therapy, caffeine, cautious corticosteroid use, and nutritional support, though targeted therapies are limited.
Conclusions:
- BPD results from complex interactions between developmental immaturity and injurious exposures.
- Improved understanding of disease mechanisms and risk stratification can enhance prevention and early intervention.
- Future research should prioritize targeted therapies to improve short- and long-term outcomes for preterm infants with BPD.
Introduction:
Bronchopulmonary dysplasia (BPD) is the most common chronic lung disease of prematurity and remains a leading cause of morbidity in extremely preterm infants. Despite advances in neonatal intensive care, BPD continues to be associated with substantial respiratory and neurodevelopmental sequelae. This review summarizes current evidence regarding the pathophysiology, risk factors, and therapeutic strategies for BPD.
Methods:
A comprehensive search of PubMed, Web of Science, and Embase was conducted using the terms "bronchopulmonary dysplasia", "premature infants", "pathophysiology", "risk factors", and "treatment". English-language studies published up to 2025 were screened, and relevant original studies, reviews, and metaanalyses were included for narrative synthesis.
Results:
Current evidence indicates that BPD is a multifactorial disorder characterized by impaired alveolarization and pulmonary vascular development resulting from the interaction of prenatal and postnatal injuries. Key pathogenic pathways include oxidative stress, inflammation, dysregulated angiogenesis, and abnormal tissue repair. Prenatal factors such as chorioamnionitis, placental dysfunction, fetal growth restriction, and genetic susceptibility increase vulnerability, while postnatal exposures including oxygen toxicity, mechanical ventilation, infection, and inadequate nutrition further contribute to disease progression. Evidence-based preventive and therapeutic approaches include lung-protective ventilation, early surfactant therapy, caffeine administration, cautious use of postnatal corticosteroids, and optimization of nutritional support. Nevertheless, targeted therapies remain limited.
Conclusions:
BPD develops through complex interactions between developmental immaturity and multiple injurious exposures before and after birth. Improved understanding of disease mechanisms and risk stratification may enhance prevention and early intervention, while future research should focus on targeted therapies to improve both short- and long-term outcomes in preterm infants.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Pulmonary Cycle: Exhalation
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease I: Introduction
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...